Diltiazem Pregnancy and Breastfeeding Warnings
Diltiazem is also known as: Cardizem, Cardizem CD, Cardizem LA, Cardizem Monovial, Cardizem SR, Cartia XT, Dilacor XR, Dilt-XR, Diltia XT, Diltiazem Hydrochloride CD, Diltiazem Hydrochloride SR, Diltiazem Hydrochloride XR, Diltiazem Hydrochloride XT, Diltzac, Matzim LA, Taztia XT, Tiazac
Diltiazem Pregnancy Warnings
Diltiazem has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of embryolethality, fetolethality, and teratogenicity. There are no controlled data in human pregnancy. Diltiazem should only be given during pregnancy when benefit outweighs risk.
A retrospective review of 78 women with first-trimester exposure to calcium channel blockers (CCBs) (13% or 10 were taking diltiazem) revealed no increase in major malformations compared with a control group matched for maternal age and smoking. This review suggests that CCBs do not represent a major teratogenic risk. A 34-year-old woman who was taking diltiazem 60 mg and isosorbide dinitrate 20 mg four times a day for angina pectoris delivered healthy, normal twins at 37 weeks' gestation. No adverse effects in the infants were observed.
Diltiazem Breastfeeding Warnings
A 34-year-old woman who was taking diltiazem 60 mg and isosorbide dinitrate 20 mg four times a day for angina pectoris safely nursed her twins during their first six months of life. No adverse effects in the infants were observed. A 40-year-old woman who was taking diltiazem 60 mg four times a day chose not to nurse. Her milk to serum diltiazem level ratio was nearly 1:1, indicating free diffusion of diltiazem into human milk.
Diltiazem is excreted into human milk. One report suggests that concentrations in breast milk may approximate serum levels. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
- Diltiazem use while Breastfeeding (in more detail)
- Diltiazem Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.